BioCentury
ARTICLE | Financial News

Follow-on roundup: Horizon, Akebia

April 18, 2015 12:53 AM UTC

Horizon Pharma plc (NASDAQ:HZNP) raised $433.6 million through the sale of 15.4 million shares at $28.25 in a follow-on underwritten by Citigroup; Jefferies; Cowen; and Morgan Stanley. Horizon proposed the offering Monday, when its shares were valued at $28.49; it priced the offering after market close Wednesday, and gained $1.47 on Thursday before shedding $0.15 to $30.82 Friday. Last week, FDA granted Fast Track designation to Horizon's Actimmune interferon (IFN) gamma-1b to treat Friedreich's ataxia. The company expects to begin a Phase III trial this quarter. ...